Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.

This study tests a combination drug called Berlim 25/20 (which combines two medications that lower blood sugar and cholesterol) in people with Type 2 diabetes and high cholesterol who have not achieved adequate blood sugar or cholesterol control with their current treatment. **You may be eligible if...** - You are between 18 and 85 years old - You have Type 2 diabetes with HbA1c (3-month blood sugar average) between 7.5% and 10.5% - You have high cardiovascular risk and have not reached LDL cholesterol goals despite current treatment - Your BMI is between 19 and 45 - You have been on stable diabetes and/or cholesterol-lowering medication for the past 3 months **You may NOT be eligible if...** - You have Type 1 diabetes - You have significant health conditions that would interfere with the study in the investigator's judgment - You have a history of alcohol or drug abuse - You are currently in another clinical trial - You are pregnant or planning to become pregnant Talk to your doctor to see if this trial is right for you.